Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/33481| Title: | Penicillin Allergy Impact and Management. | Austin Authors: | Wrenn, Rebekah H;Trubiano, Jason | Affiliation: | Duke University Medical Center, Durham, NC, USA; Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC, USA. Infectious Diseases Department of Infectious Diseases, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Victoria 3000, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Centre for Antibiotic Allergy and Research |
Issue Date: | 1-Aug-2023 | Date: | 2023 | Publication information: | Infectious Disease Clinics of North America 2023-08-01 | Abstract: | There is international evidence that penicillin allergies are associated with inferior prescribing and patient outcomes. A host of tools now exist from assessment (risk assessment tools, clinical decision rules) to delabeling (the removal of a beta-lactam allergy via testing or medical reconciliation) to reduce the impact of these "labels" in the hospital and community setting, as a primary antimicrobial stewardship intervention. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/33481 | DOI: | 10.1016/j.idc.2023.06.005 | ORCID: | Journal: | Infectious Disease Clinics of North America | PubMed URL: | 37537003 | ISSN: | 1557-9824 | Type: | Journal Article | Subjects: | Delabeling Drug allergy Oral challenge Penicillin allergy |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.